Merck and Co receives FDA approval for Keytruda in further indications
In: Chemical Business Newsbase, 2018-10-30
Zeitungsartikel
Zugriff:
The US Food and Drug Administration (FDA) has approved Merck and Co's cancer drug Keytruda in combination with chemotherapy for a specific form of lung cancer. Data from a phase 3 trial, which showed a better survival rate using Keytruda in combination with chemotherapy compared to chemotherapy alone, supported the approval. Original Source: Chemie Aktuell, http://www.maerkte-weltweit.de, Copyright MBM Martin Brueckner Medien GmbH 2018.
Titel: |
Merck and Co receives FDA approval for Keytruda in further indications
|
---|---|
Zeitschrift: | Chemical Business Newsbase, 2018-10-30 |
Veröffentlichung: | 2018 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|